Ventana Biotech Stock Analysis
| VNTA Stock | USD 0.0004 0.00 0.00% |
Ventana Biotech is overvalued with Real Value of 3.84E-4 and Hype Value of 3.71E-4. The main objective of Ventana Biotech pink sheet analysis is to determine its intrinsic value, which is an estimate of what Ventana Biotech is worth, separate from its market price. There are two main types of Ventana Biotech's stock analysis: fundamental analysis and technical analysis.
The Ventana Biotech pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Ventana Biotech's ongoing operational relationships across important fundamental and technical indicators.
Ventana |
Ventana Pink Sheet Analysis Notes
The company recorded a loss per share of 0.0. Ventana Biotech had not issued any dividends in recent years. The entity had 92:1 split on the 20th of November 2008. Ventana Biotech, Inc., a development stage biotech company, identifies, evaluates, acquires, develops, and partners commercialization of intellectual property in the area of drug candidates for personalized medicine. Ventana Biotech, Inc. was founded in 1989 and is based in Butschwil, Switzerland. Ventana Biotech is traded on OTC Exchange in the United States.The quote for Ventana Biotech is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call the company at 41 44 732 60 59.Ventana Biotech Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more pink sheets at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Ventana Biotech's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Ventana Biotech or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Ventana Biotech is way too risky over 90 days horizon | |
| Ventana Biotech has some characteristics of a very speculative penny stock | |
| Ventana Biotech appears to be risky and price may revert if volatility continues | |
| Ventana Biotech has high likelihood to experience some financial distress in the next 2 years | |
| The company has a current ratio of 0.02, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Ventana Biotech until it has trouble settling it off, either with new capital or with free cash flow. So, Ventana Biotech's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Ventana Biotech sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Ventana to invest in growth at high rates of return. When we think about Ventana Biotech's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (47.08 K) with loss before overhead, payroll, taxes, and interest of (260). | |
| Ventana Biotech generates negative cash flow from operations |
Ventana Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 192.73 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ventana Biotech's market, we take the total number of its shares issued and multiply it by Ventana Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 24th of November, Ventana Biotech has the Risk Adjusted Performance of 0.0949, coefficient of variation of 902.67, and Semi Deviation of 17.44. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Ventana Biotech, as well as the relationship between them.Ventana Biotech Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Ventana Biotech middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Ventana Biotech. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Ventana Biotech Predictive Daily Indicators
Ventana Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Ventana Biotech pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 4.0E-4 | |||
| Day Typical Price | 4.0E-4 | |||
| Relative Strength Index | 96.06 |
Ventana Biotech Forecast Models
Ventana Biotech's time-series forecasting models are one of many Ventana Biotech's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Ventana Biotech's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Ventana Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Ventana Biotech prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Ventana shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Ventana Biotech. By using and applying Ventana Pink Sheet analysis, traders can create a robust methodology for identifying Ventana entry and exit points for their positions.
Ventana Biotech, Inc., a development stage biotech company, identifies, evaluates, acquires, develops, and partners commercialization of intellectual property in the area of drug candidates for personalized medicine. Ventana Biotech, Inc. was founded in 1989 and is based in Butschwil, Switzerland. Ventana Biotech is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Ventana Biotech to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Complementary Tools for Ventana Pink Sheet analysis
When running Ventana Biotech's price analysis, check to measure Ventana Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ventana Biotech is operating at the current time. Most of Ventana Biotech's value examination focuses on studying past and present price action to predict the probability of Ventana Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ventana Biotech's price. Additionally, you may evaluate how the addition of Ventana Biotech to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |